Align Capital Partners’ (“ACP”) toxicology testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired Desert Tox, LLC (“Desert Tox”), a provider of Substance Abuse and Mental Health Services Administration (“SAMHSA”) certified laboratory testing services. Desert Tox serves customers throughout the United States across a broad range of end markets, including HHS/DOT, employment, occupational health and government markets. Desert Tox marks Premier’s first add-on since ACP’s acquisition of the Company in November of 2022. Premier will continue to pursue strategic acquisitions to enhance and broaden Premier’s industry-leading portfolio of diagnostic products and services.
Read the full article: Premier Biotech Expands Service Offering with Desert Tox Acquisition //
Source: https://www.businesswire.com/news/home/20240606686322/en/Premier-Biotech-Expands-Service-Offering-with-Desert-Tox-Acquisition